Cargando…
402. Breakthrough Pneumocystis jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship?
BACKGROUND: Despite available prophylaxis, Pneumocystis jirovecii pneumonia (PJP) still occurs in immunocompromised hosts. We set out to determine the overall burden of PJP among cancer patients in the modern era at our cancer center. Furthermore, we sought to describe reasons for failure to use pro...
Autores principales: | Roncaioli, Steven, Bryan, Andrew, Stohs, Erica, Liu, Catherine, Sweet, Ania, Pergam, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253927/ http://dx.doi.org/10.1093/ofid/ofy210.413 |
Ejemplares similares
-
Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients
por: Stohs, Erica, et al.
Publicado: (2017) -
Pneumocystis jirovecii pneumonia in developing countries
por: De Armas Rodríguez, Y., et al.
Publicado: (2011) -
139. association of Physician Orders for Life-sustaining Treatment (POLST) with Antimicrobial Use at End of Life in Cancer Patients: An Antimicrobial Stewardship Opportunity
por: Kates, Olivia, et al.
Publicado: (2020) -
Sulfa Use, Dihydropteroate Synthase Mutations, and Pneumocystis jirovecii Pneumonia
por: Stein, Cheryl R., et al.
Publicado: (2004) -
Atypical radiographic manifestation in Pneumocystis jirovecii pneumonia
por: Yamakuchi, Hiroki
Publicado: (2017)